LH

Mark S. Schroeder

Known title: EVP, President-Diagnostics LabCIK: 0001793112

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.

this person other insiders at LH

Transaction History

LH▲ Buy$0
LH▼ Sell$1.2M
LH▲ Buy$0
LH▼ Sell$394K
LH▲ Buy—
LH▼ Sell$75K
LH▼ Sell$15K
LH▼ Sell$45K
LH▲ Buy—
LH▲ Buy—
LH▼ Sell$66K
LH▲ Buy—
LH▼ Sell$610K
LH▼ Sell$511K
LH▲ Buy$0
LH▲ Buy$513K
LH▼ Sell$1.3M
LH▲ Buy—
LH▼ Sell$33K
LH▼ Sell$12K
LH▲ Buy—
LH▼ Sell$36K
LH▲ Buy—
LH▲ Buy—
LH▼ Sell$52K
LH▼ Sell$1.4M
LH▲ Buy—
LH▼ Sell$1.1M
LH▼ Sell$1.1M
LH▲ Buy$248K
LH▼ Sell$29K
LH▲ Buy—
LH▼ Sell$31K
LH▲ Buy—
LH▼ Sell$10K
LH▲ Buy—
LH▼ Sell$29K
LH▲ Buy—
LH▼ Sell$325K
LH▲ Buy$196K
LH▼ Sell$880K
LH▲ Buy$0
LH▼ Sell$644K
LH▼ Sell$77K
LH▼ Sell$28K
LH▲ Buy—
LH▼ Sell$99K
LH▼ Sell$37K
LH▲ Buy—
LH▼ Sell$82K
LH▲ Buy—
LH▼ Sell$30K
LH▼ Sell$260K
LH▼ Sell$209K
LH▲ Buy—
LH▼ Sell$653K
LH▼ Sell$521K
LH▲ Buy$0
LH▼ Sell$57K
LH▼ Sell$21K
LH▲ Buy—
LH▼ Sell$57K
LH▼ Sell$42K
LH▲ Buy—
LH▼ Sell$44K
LH▲ Buy—
LH▼ Sell$33K
LH▼ Sell$247K
LH▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.